Combined deficiency in CD44 and fas leads to exacerbation of lymphoproliferative and autoimmune disease

International Immunology

Volumn 15, Issue 11, 2003, Pages 1327-1340

  Do, Yoonkyung ^a   Rafi Janajreh, Asimah Q ^b   Mckallip, Robert J ^a   Nagarkatti, Prakash S ^a   Nagarkatti, Mitzi ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NONE

Author keywords

Activation induced cell death; Apoptosis; Autoantibody; Double negative T cells; Lupus

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; DNA ANTIBODY; FAS ANTIGEN; HERMES ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SINGLE STRANDED DNA; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CELL DEATH; CHROMATIN; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPH NODE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD45; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CHROMATIN; DNA, SINGLE-STRANDED; FEMALE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-2; LYMPH NODES; LYMPHATIC DISEASES; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, KNOCKOUT; RECOMBINANT PROTEINS; SPLEEN; THYMUS GLAND;

EID: 0242551621     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg132     Document Type: Article

References (57)

1. Sneller, M. C., Straus, S. E., Jaffe, E. S., Jaffe, J. S., Fleisher, T. A., Stetler-Stevenson, M. and Strober, W. 1992. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest. 90:334.
2. Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middelton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., Lenardo, M. J. and Straus, S. E. 1997. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341.
3. Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B. and Dixon, F. J. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198.
4. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
5. Davidson, W. F., Giese, T. and Fredrickson, T. N. 1998. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J. Exp. Med. 187:1825.
6. Siegel, R. M. and Fleisher, T. A. 1999. The role of Fas and related death receptors in autoimmune and other disease states. J. Allergy Clin. Immunol. 103:729.
7. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
8. Martin, D. A., Zheng, L., Siegel, R. M., Huang, B., Fisher, G. H., Wang, J., Jackson, C. E., Puck, J. M., Dale, J., Straus, S. E., Peter, M. E., Krammer, P. H., Fesik, S. and Lenardo, M. J. 1999. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia, Proc. Natl Acad. Sci. USA. 96:4552.
9. Green, D. R. and Scott, D. W. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476.
10. Kabelitz, D., Pohl, T. and Pechhold, K. 1993. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14:338.
11. Wesselborg, S., Janssen, O. and Kabelitz, D. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
12. Morse, H. C., III, Davidson, W. F., Yetter, R. A., Murphy, E. D., Roths, J. B. and Coffman, R. L. 1982. Abnormalities induced by the mutant gene lpr. expansion of a unique lymphocyte subset. J. Immunol. 129:2612.
13. Dumont, F. J., Habbersett, R. C. and Nichols, E. A. 1984. A new lymphocyte surface antigen defined by a monoclonal antibody (9F3) to the T cell population expanding in MRL/Mp-lpr/lpr mice. J. Immunol. 133:809.
14. Lesley, J., Hyman, R. and Kincade, P. W. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271.
15. Hammond, D. M., Nagarkatti, P. S., Gote, L. R., Seth, A., Hassuneh, M. R. and Nagarkatti, M. 1993. Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J. Exp. Med. 178:2225.
16. Rafi-Janajreh, A. Q., Nagarkatti, P. S. and Nagarkatti, M. 1998. Role of CD44 in CTL and NK cell activity. Front. Biosci. 3:D665.
17. Seth, A., Gote, L., Nagarkatti, M. and Nagarkatti, P. S. 1991. T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14. Proc. Natl Acad. Sci. USA 88:7877.
18. Rafi-Janajreh, A. Q., Chen, D., Schmits, R., Mak, T. W., Grayson, R. L., Sponenberg, D. P., Nagarkatti, M. and Nagarkatti, P. S. 1999. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J. Immunol. 163:1619.
19. Chen, D., McKallip, R. J., Zeytun, A., Do, Y., Lombard, C., Robertson, J. L., Mak, T. W., Nagarkatti, P. S. and Nagarkatti, M. 2001. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J. Immunol. 166:5889.
20. McKallip, R. J., Do, Y., Fisher, M. T., Robertson, J. L., Nagarkatti, P. S. and Nagarkatti, M. 2002. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int. Immunol. 14:1015.
21. + T cytotoxic cells. Int. J. Cancer 45:1096.
22. Seth, A., Pyle, R. H., Nagarkatti, M. and Nagarkatti, P. S. 1988. Expression of the J11d marker on peripheral T lymphocytes of MRL-lpr/lpr mice. J. Immunol. 141:1120.
23. - T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties. Cell. Immunol. 127:442.
24. + T cells in lpr/lpr mice. J. Exp. Med. 172:1805.
25. Nagarkatti, P. S., Seth, A., Nagarkatti, M., Muthusamy, N., Rychlik, B. and Subbarao, B. 1989. A specific defect in the proliferative capacity of B cells from old mice stimulated with autoreactive T cells. Cell. Immunol. 120:102.
26. He, H., Hershberger, P. A. and McCarthy, S. A. 1998. Down-modulation of a novel Bax-associated protein during apoptosis in normal mature B lymphocytes. J. Immunol. 161:1176.
27. Yoshida, T., Higuchi, T., Hagiyama, H., Strasser, A., Nishioka, K. and Tsubata, T. 2000. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int. Immunol. 12:517.
28. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
29. Hodgkin, P. D., Lee, J. H. and Lyons, A. B. 1996. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184:277.
30. Krishan, A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66:188.
31. Theofilopoulos, A. N. and Dixon, F. J. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269.
32. Renno, T., Attinger, A., Rimoldi, D., Hahne, M., Tschopp, J. and MacDonald, H. R. 1998. Expression of B220 on activated T cell blasts precedes apoptosis. Eur. J. Immunol. 28:540.
33. Cohen, P. L. and Eisenberg, R. A. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
34. Izui, S., Kelley, V. E., Masuda, K., Yoshida, H., Roths, J. B. and Murphy, E. D. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
35. Radvanyi, L. G., Raju, K., Spaner, D., Mills, G. B. and Miller, R. G. 1998. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice. Cell. Immunol. 183:1.
36. Hieronymus, T., Blank, N., Gruenke, M., Winkler, S., Haas, J. P., Kalden, J. R. and Lorenz, H. M. 2000. CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes. Cell Death Differ. 7:538.
37. Vidal, S., Kono, D. H. and Theofilopoulos, A. N. 1998. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Fas lpr mice. J. Clin. Invest. 101:696.
38. Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N. and Nagata, S. 1998. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice. J. Immunol. 160:3805,
39. Giese, T. and Davidson, W. F. 1994. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J. Immunol. 152:2000.
40. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985.
41. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
42. fyn in their activation and expansion. J. Immunol. 159:2265.
43. Maldonado, M. A., Eisenberg, R. A., Roper, E., Cohen, P. L. and Kotzin, B. L. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181:641.
44. + T cells creates double-negative cells in vivo. J. Immunol. 161:1686.
45. + cells based on high affinity TCR signals. J. Immunol. 162:5747.
46. Van Houten, N. and Budd, R. C. 1992. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J. Immunol. 149:2513.
47. Haynes, B. F., Telen, M. J., Hale, L. P. and Denning, S. M. 1989. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10:423.
48. Denning, S. M., Le, P. T., Singer, K. H. and Haynes, B. F. 1990. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144:7.
49. Shimizu, Y., Van Seventer, G. A., Siraganian, R., Wahl, L. and Shaw, S. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:2457.
50. Rafi, A., Nagarkatti, M. and Nagarkatti, P. S. 1997. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 89:2901.
51. Noble, P. W., Lake, F. R., Henson, P. M. and Riches, D. W. 1993. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J. Clin. Invest. 91:2368.
52. Kryworuckho, M., Diaz-Mitoma, F. and Kumar, A. 1995. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Immunology 86:41.
53. Galluzzo, E., Albi, N., Fiorucci, S., Merigiola, C., Ruggeri, L., Tosti, A., Grossi, C. E. and Velardi, A. 1995. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur. J. Immunol. 25:2932.
54. Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Kohler, G., Schopf, E., Ponta, H., Herrlich, P. and Simon, J. C. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137.
55. Wittig, B. M., Johansson, B., Zoller, M., Schwarzler, C. and Gunthert, U. 2000. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J. Exp. Med. 191:2053.
56. Foger, N., Marhaba, R. and Zoller, M. 2000. CD44 supports T cell proliferation and apoptosis by apposition of protein kinases. Eur. J. Immunol. 30:2888.
57. Shenoy, S., Mohanakumar, T., Chatila, T., Tersak, J., Duffy, B., Wang, R., Thilenius, A. R. and Russell, J. H. 2001. Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias. Clin. Immunol. 99:266.